• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便免疫化学检测阳性后结肠镜检查不依从会使结直肠癌死亡风险增加一倍。

Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer.

机构信息

Veneto Tumour Registry, Azienda Zero, Padova, Italy

Veneto Tumour Registry, Azienda Zero, Padova, Italy.

出版信息

Gut. 2022 Mar;71(3):561-567. doi: 10.1136/gutjnl-2020-322192. Epub 2021 Mar 31.

DOI:10.1136/gutjnl-2020-322192
PMID:33789965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8862019/
Abstract

BACKGROUND

The risk of colorectal cancer (CRC) among subjects with a positive faecal immunochemical test (FIT) who do not undergo a colonoscopy is unknown. We estimated whether non-compliance with colonoscopy after a positive FIT is associated with increased CRC incidence and mortality.

METHODS

The FIT-based CRC screening programme in the Veneto region (Italy) invited persons aged 50 to 69 years with a positive FIT (>20 µg Hb/g faeces) for diagnostic colonoscopy at an endoscopic referral centre. In this retrospective cohort study, we compared the 10-year cumulative CRC incidence and mortality among FIT positives who completed a diagnostic colonoscopy within the programme (compliers) and those who did not (non-compliers), using the Kaplan-Meier estimator and Cox-Aalen models.

RESULTS

Some 88 013 patients who were FIT positive complied with colonoscopy (males: 56.1%; aged 50-59 years: 49.1%) while 23 410 did not (males: 54.6%; aged 50-59 years: 44.9%).The 10-year cumulative incidence of CRC was 44.7 per 1000 (95% CI, 43.1 to 46.3) among colonoscopy compliers and 54.3 per 1000 (95% CI, 49.9 to 58.7) in non-compliers, while the cumulative mortality for CRC was 6.8 per 1000 (95% CI, 5.9 to 7.6) and 16.0 per 1000 (95% CI, 13.1 to 18.9), respectively. The risk of dying of CRC among non-compliers was 103% higher than among compliers (adjusted HR, 2.03; 95% CI, 1.68 to 2.44).

CONCLUSION

The excess risk of CRC death among those not completing colonoscopy after a positive faecal occult blood test should prompt screening programmes to adopt effective interventions to increase compliance in this high-risk population.

摘要

背景

粪便免疫化学检测(FIT)阳性但未行结肠镜检查的患者罹患结直肠癌(CRC)的风险尚不清楚。我们评估了 FIT 阳性后不进行结肠镜检查是否与 CRC 发病率和死亡率增加相关。

方法

意大利威尼托地区基于 FIT 的 CRC 筛查项目邀请了年龄在 50 至 69 岁之间、FIT 阳性(粪便血红蛋白>20μg/g)的人群到内镜转诊中心进行诊断性结肠镜检查。在这项回顾性队列研究中,我们使用 Kaplan-Meier 估计值和 Cox-Aalen 模型比较了在项目内完成诊断性结肠镜检查的 FIT 阳性者(依从者)和未完成者(不依从者)的 10 年 CRC 累计发病率和死亡率。

结果

88013 名 FIT 阳性者接受了结肠镜检查(男性占 56.1%;年龄 50-59 岁者占 49.1%),23410 名 FIT 阳性者未接受结肠镜检查(男性占 54.6%;年龄 50-59 岁者占 44.9%)。结肠镜检查依从者的 10 年 CRC 累计发病率为 44.7/1000(95%CI,43.1 至 46.3),不依从者为 54.3/1000(95%CI,49.9 至 58.7),CRC 累计死亡率分别为 6.8/1000(95%CI,5.9 至 7.6)和 16.0/1000(95%CI,13.1 至 18.9)。不依从者 CRC 死亡风险比依从者高 103%(校正 HR,2.03;95%CI,1.68 至 2.44)。

结论

粪便潜血试验阳性后不进行结肠镜检查的患者 CRC 死亡风险增加,这应促使筛查项目采取有效干预措施,提高高危人群的依从性。

相似文献

1
Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer.粪便免疫化学检测阳性后结肠镜检查不依从会使结直肠癌死亡风险增加一倍。
Gut. 2022 Mar;71(3):561-567. doi: 10.1136/gutjnl-2020-322192. Epub 2021 Mar 31.
2
Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.结肠镜检查阴性后的粪便免疫化学试验可能降低基于人群的筛查计划中结直肠癌的发病风险。
Gut. 2021 Jul;70(7):1318-1324. doi: 10.1136/gutjnl-2020-320761. Epub 2020 Sep 28.
3
Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?使用粪便免疫化学检测的基于人群的结直肠癌筛查项目:粪便血红蛋白临界值应因年龄和性别而异吗?
BMC Cancer. 2017 Aug 29;17(1):577. doi: 10.1186/s12885-017-3555-3.
4
Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in Italy.粪便血红蛋白浓度在 FIT 结果阴性的人群中与后续轮次的肿瘤检出率相关:意大利基于人群筛查项目的前瞻性研究。
Gut. 2020 Mar;69(3):523-530. doi: 10.1136/gutjnl-2018-318198. Epub 2019 Aug 27.
5
One or two faecal immunochemical tests in an organised population-based colorectal cancer screening programme in Murcia (Spain).在西班牙穆尔西亚(Murcia)的一个有组织的基于人群的结直肠癌筛查计划中进行一次或两次粪便免疫化学检测。
J Med Screen. 2022 Dec;29(4):231-240. doi: 10.1177/09691413221094919. Epub 2022 May 16.
6
Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.基于愈创木脂的粪便潜血试验与粪便免疫化学试验用于一般风险人群结直肠癌筛查。
Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD009276. doi: 10.1002/14651858.CD009276.pub2.
7
Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.粪便免疫化学试验与结肠镜检查用于息肉切除术后监测的比较:一项准确性、可接受性和经济学研究。
Health Technol Assess. 2019 Jan;23(1):1-84. doi: 10.3310/hta23010.
8
Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.基于粪便免疫化学试验的结直肠癌筛查方案的长期效果。
Gut. 2018 Dec;67(12):2124-2130. doi: 10.1136/gutjnl-2017-314753. Epub 2017 Nov 3.
9
Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme.预防潜力:一项基于粪便免疫化学检测的结直肠癌筛查项目中结肠镜检查及腺瘤切除的队列研究
Scand J Gastroenterol. 2019 Aug;54(8):1008-1014. doi: 10.1080/00365521.2019.1647282. Epub 2019 Aug 9.
10
Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.粪便血红蛋白可定义结直肠腺瘤性息肉患者在结直肠肿瘤筛查中风险。
United European Gastroenterol J. 2020 Jun;8(5):559-566. doi: 10.1177/2050640620913674. Epub 2020 Mar 16.

引用本文的文献

1
Modeled Cost-Effectiveness of a Rideshare Program to Facilitate Colonoscopy Completion.一项促进结肠镜检查完成的拼车计划的模拟成本效益分析。
JAMA Netw Open. 2025 Sep 2;8(9):e2530515. doi: 10.1001/jamanetworkopen.2025.30515.
2
Assessing the impact of a single qualitative fecal immunochemical test on colonoscopy prioritization and mortality in risk-stratified patients with suspected colorectal cancer: a retrospective cohort study.评估单次定性粪便免疫化学检测对疑似结直肠癌风险分层患者结肠镜检查优先级及死亡率的影响:一项回顾性队列研究。
Lancet Reg Health Am. 2025 Aug 11;50:101201. doi: 10.1016/j.lana.2025.101201. eCollection 2025 Oct.
3

本文引用的文献

1
Colonoscopy later than 270 days in a fecal immunochemical test-based population screening program is associated with higher prevalence of colorectal cancer.在基于粪便免疫化学试验的人群筛查计划中,结肠镜检查晚于 270 天与结直肠癌的更高患病率相关。
Endoscopy. 2020 Oct;52(10):871-876. doi: 10.1055/a-1159-0644. Epub 2020 Apr 30.
2
Association between time to colonoscopy after a positive guaiac fecal test result and risk of colorectal cancer and advanced stage disease at diagnosis.便潜血阳性后的结肠镜检查时间与结直肠癌及诊断时晚期疾病发病风险的相关性。
Int J Cancer. 2020 Mar 15;146(6):1532-1540. doi: 10.1002/ijc.32497. Epub 2019 Jul 4.
3
Comparing the effectiveness of implementation strategies to improve liver and colon cancer screening for Veterans: protocol for a large cluster-randomized implementation study.
比较改善退伍军人肝癌和结肠癌筛查实施策略的有效性:一项大型整群随机实施研究的方案
Implement Sci. 2025 Aug 9;20(1):38. doi: 10.1186/s13012-025-01448-1.
4
Health Policy and Screening for Colorectal Cancer in the United States.美国的卫生政策与结直肠癌筛查
Cancers (Basel). 2025 Jun 16;17(12):2003. doi: 10.3390/cancers17122003.
5
The Value of Clinical Decision Support in Healthcare: A Focus on Screening and Early Detection.临床决策支持在医疗保健中的价值:聚焦筛查与早期检测
Diagnostics (Basel). 2025 Mar 6;15(5):648. doi: 10.3390/diagnostics15050648.
6
Development of Electronic Nose as a Complementary Screening Tool for Breath Testing in Colorectal Cancer.电子鼻作为结直肠癌呼气检测辅助筛查工具的开发
Biosensors (Basel). 2025 Feb 1;15(2):82. doi: 10.3390/bios15020082.
7
Delays in Diagnostic Colonoscopy After Positive FIT in an Integrated Healthcare System.综合医疗系统中粪便免疫化学试验呈阳性后诊断性结肠镜检查的延迟情况。
Dig Dis Sci. 2025 Mar;70(3):991-995. doi: 10.1007/s10620-025-08848-9. Epub 2025 Jan 22.
8
How Good Is Good Enough? What Should Be the Target for CRC Screening?多好才算足够好?结直肠癌筛查的目标应该是什么?
Dig Dis Sci. 2024 Dec 13. doi: 10.1007/s10620-024-08698-x.
9
Longer travel times to acute hospitals are associated with lower likelihood of cancer screening receipt among rural-dwelling adults in the U.S. South.在美国南部农村地区的成年人中,前往急症医院的路途时间越长,接受癌症筛查的可能性就越低。
Cancer Causes Control. 2025 Mar;36(3):297-308. doi: 10.1007/s10552-024-01940-x. Epub 2024 Nov 22.
10
5-Hydroxymethylated Biomarkers in Cell-Free DNA Predict Occult Colorectal Cancer up to 36 Months Before Diagnosis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.循环游离 DNA 中 5-羟甲基化的生物标志物可在前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验中预测出诊断前长达 36 个月的隐匿性结直肠癌。
JCO Precis Oncol. 2024 Oct;8:e2400277. doi: 10.1200/PO.24.00277. Epub 2024 Oct 11.
GPs' perspectives on colorectal cancer screening and their potential influence on FIT-positive patients: an exploratory qualitative study from a Dutch context.
全科医生对结直肠癌筛查的看法及其对粪便免疫化学检测阳性患者的潜在影响:一项来自荷兰的探索性定性研究
BJGP Open. 2019 Mar 20;3(1):bjgpopen18X101631. doi: 10.3399/bjgpopen18X101631. eCollection 2019 Apr.
4
The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis.粪便潜血试验阳性后的第二次诊断评估的依从率:系统评价和荟萃分析。
United European Gastroenterol J. 2019 Apr;7(3):424-448. doi: 10.1177/2050640619828185. Epub 2019 Feb 6.
5
Long-term Risk of Colorectal Cancer and Related Deaths After a Colonoscopy With Normal Findings.结肠镜检查正常结果后的结直肠癌长期风险和相关死亡。
JAMA Intern Med. 2019 Feb 1;179(2):153-160. doi: 10.1001/jamainternmed.2018.5565.
6
Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests.粪便免疫化学检测阳性患者行结肠镜检查的时间与结直肠癌风险。
Clin Gastroenterol Hepatol. 2019 Jun;17(7):1332-1340.e3. doi: 10.1016/j.cgh.2018.10.041. Epub 2018 Nov 1.
7
Barriers to Follow-up Colonoscopies for Patients With Positive Results From Fecal Immunochemical Tests During Colorectal Cancer Screening.结直肠癌筛查中粪便免疫化学试验阳性患者行结肠镜随访的障碍。
Clin Gastroenterol Hepatol. 2019 Feb;17(3):469-476. doi: 10.1016/j.cgh.2018.05.022. Epub 2018 May 29.
8
The IARC Perspective on Colorectal Cancer Screening.国际癌症研究机构对结直肠癌筛查的观点。
N Engl J Med. 2018 May 3;378(18):1734-1740. doi: 10.1056/NEJMsr1714643. Epub 2018 Mar 26.
9
Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.基于粪便免疫化学试验的结直肠癌筛查方案的长期效果。
Gut. 2018 Dec;67(12):2124-2130. doi: 10.1136/gutjnl-2017-314753. Epub 2017 Nov 3.
10
Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review.改善粪便潜血试验阳性结果随访的干预措施:一项系统评价
Ann Intern Med. 2017 Oct 17;167(8):565-575. doi: 10.7326/M17-1361. Epub 2017 Oct 10.